Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease

Neurobiology of Aging

Volumn 38, Issue , 2015, Pages 216.e7-216.e10

  Pyle, Angela ^a   Anugrha, Haidyan ^a   Kurzawa Akanbi, Marzena ^a   Yarnall, Alison ^b   Burn, David ^b   Hudson, Gavin ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Biomarker; Mitochondria; Parkinson's disease

Indexed keywords

MITOCHONDRIAL DNA; BIOLOGICAL MARKER;

ARTICLE; BLOOD SAMPLING; BRAIN TISSUE; CONTROLLED STUDY; DISEASE MARKER; DNA CONTENT; DNA DETERMINATION; FEMALE; FRONTAL CORTEX; GENE DOSAGE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SUBSTANTIA NIGRA PARS COMPACTA; TISSUE DISTRIBUTION; UNITED KINGDOM; COHORT ANALYSIS; COPY NUMBER VARIATION; GENETIC ASSOCIATION STUDY; GENETICS;

BIOMARKERS; COHORT STUDIES; DNA COPY NUMBER VARIATIONS; DNA, MITOCHONDRIAL; GENETIC ASSOCIATION STUDIES; HUMANS; PARKINSON DISEASE;

EID: 85017082030     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.10.033     Document Type: Article

References (24)

1. Davis G.C., Williams A.C., Markey S.P., Ebert M.H., Caine E.D., Reichert C.M., Kopin I.J. Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1979, 1:249-254.
2. Feng Y.M., Jia Y.F., Su L.Y., Wang D., Lv L., Xu L., Yao Y.G. Decreased mitochondrial DNA copy number in the hippocampus and peripheral blood during opiate addiction is mediated by autophagy and can be salvaged by melatonin. Autophagy 2013, 9:1395-1406.
3. Ghezzi D., Marelli C., Achilli A., Goldwurm S., Pezzoli G., Barone P., Pellecchia M.T., Stanzione P., Brusa L., Bentivoglio A.R., Bonuccelli U., Petrozzi L., Abbruzzese G., Marchese R., Cortelli P., Grimaldi D., Martinelli P., Ferrarese C., Garavaglia B., Sangiorgi S., Carelli V., Torroni A., Albanese A., Zeviani M. Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur. J. Hum. Genet. 2005, 13:748-752.
4. Giordano C., Iommarini L., Giordano L., Maresca A., Pisano A., Valentino M.L., Caporali L., Liguori R., Deceglie S., Roberti M., Fanelli F., Fracasso F., Ross-Cisneros F.N., D'Adamo P., Hudson G., Pyle A., Yu-Wai-Man P., Chinnery P.F., Zeviani M., Salomao S.R., Berezovsky A., Belfort R., Ventura D.F., Moraes M., Moraes Filho M., Barboni P., Sadun F., De Negri A., Sadun A.A., Tancredi A., Mancini M., d'Amati G., Loguercio Polosa P., Cantatore P., Carelli V. Efficient mitochondrial biogenesis drives incomplete penetrance in Leber's hereditary optic neuropathy. Brain 2014, 137(Pt 2):335-353.
5. Gomez-Duran A., Pacheu-Grau D., Martinez-Romero I., Lopez-Gallardo E., Lopez-Perez M.J., Montoya J., Ruiz-Pesini E. Oxidative phosphorylation differences between mitochondrial DNA haplogroups modify the risk of Leber's hereditary optic neuropathy. Bba-mol Basis Dis. 2012, 1822:1216-1222.
6. Grady J.P., Murphy J.L., Blakely E.L., Haller R.G., Taylor R.W., Turnbull D.M., Tuppen H.A.L. Accurate measurement of mitochondrial DNA deletion level and copy number differences in human skeletal muscle. PLoS One 2014, 9:e114462.
7. Hatano Y., Li Y., Sato K., Asakawa S., Yamamura Y., Tomiyama H., Yoshino H., Asahina M., Kobayashi S., Hassin-Baer S., Lu C.S., Ng A.R., Rosales R.L., Shimizu N., Toda T., Mizuno Y., Hattori N. Novel PINK1 mutations in early-onset parkinsonism. Ann. Neurol. 2004, 56:424-427.
8. Hudson G., Gomez-Duran A., Wilson I.J., Chinnery P.F. Recent mitochondrial DNA mutations increase the risk of developing common late-onset human diseases. PLoS Genet. 2014, 10:e1004369.
9. Hudson G., Nalls M., Evans J.R., Breen D.P., Winder-Rhodes S., Morrison K.E., Morris H.R., Williams-Gray C.H., Barker R.A., Singleton A.B., Hardy J., Wood N.E., Burn D.J., Chinnery P.F. Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease. Neurology 2013, 80:2042-2048.
10. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
11. Latsoudis H., Spanaki C., Chlouverakis G., Plaitakis A. Mitochondrial DNA polymorphisms and haplogroups in Parkinson's disease and control individuals with a similar genetic background. J. Hum. Genet. 2008, 53:349-356.
12. Lee H.C., Yin P.H., Lu C.Y., Chi C.W., Wei Y.H. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem. J. 2000, 348:425-432.
13. Liou C.W., Lin T.K., Chen J.B., Tiao M.M., Weng S.W., Chen S.D., Chuang Y.C., Chuang J.H., Wang P.W. Association between a common mitochondrial DNA D-loop polycytosine variant and alteration of mitochondrial copy number in human peripheral blood cells. J. Med. Genet. 2010, 47:723-728.
14. Mills R.D., Sim C.H., Mok S.S., Mulhern T.D., Culvenor J.G., Cheng H.C. Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1). J. Neurochem. 2008, 105:18-33.
15. Morais V.A., De Strooper B. Mitochondria dysfunction and neurodegenerative disorders: cause or consequence. J. Alzheimers Dis. 2010, 20:S255-S263.
16. Mullin S., Schapira A. Alpha-Synuclein and mitochondrial dysfunction in Parkinson's disease. Mol. Neurobiol. 2013, 47:587-597.
17. Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., Cummings J.L., Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005, 53:695-699.
18. Nombela C., Rowe J.B., Winder-Rhodes S.E., Hampshire A., Owen A.M., Breen D.P., Duncan G.W., Khoo T.K., Yarnall A.J., Firbank M.J., Chinnery P.F., Robbins T.W., O'Brien J.T., Brooks D.J., Burn D.J., Barker R.A. Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain 2014, 137(Pt 10):2743-2758. ICICLE-PD Study Group.
19. Petersen M.H., Budtz-Jorgensen E., Sorensen S.A., Nielsen J.E., Hjermind L.E., Vinther-Jensen T., Nielsen S.M.B., Norremolle A. Reduction in mitochondrial DNA copy number in peripheral leukocytes after onset of Huntington's disease. Mitochondrion 2014, 17:14-21.
20. Reeve A., Meagher M., Lax N., Simcox E., Hepplewhite P., Jaros E., Turnbull D. The impact of pathogenic mitochondrial DNA mutations on substantia nigra neurons. J. Neurosci. 2013, 33:10790-10801.
21. Rice A.C., Keeney P.M., Algarzae N.K., Ladd A.C., Thomas R.R., Bennett J.P. Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer's disease hippocampi. J. Alzheimers Dis. 2014, 40:319-330.
22. Roth M., Tym E., Mountjoy C.Q., Huppert F.A., Hendrie H., Verma S., Goddard R. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br. J. Psychiatry 1986, 149:698-709.
23. Xie H., Lev D., Gong Y.L., Wang S., Pollock R.E., Wu X.F., Gu J. Reduced mitochondrial DNA copy number in peripheral blood leukocytes increases the risk of soft tissue sarcoma. Carcinogenesis 2013, 34:1039-1043.
24. Yarnall A.J., Breen D.P., Duncan G.W., Khoo T.K., Coleman S.Y., Firbank M.J., Nombela C., Winder-Rhodes S., Evans J.R., Rowe J.B., Mollenhauer B., Kruse N., Hudson G., Chinnery P.F., O'Brien J.T., Robbins T.W., Wesnes K., Brooks D.J., Barker R.A., Burn D.J., Group I.-P.S. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology 2014, 82:308-316.